You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 262 No. 14, October 13, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Investigation
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Apolipoprotein B-100 Hopkins (Arginine4019 [unk] Tryptophan)

A New Apolipoprotein B-100 Variant in a Family With Premature Atherosclerosis and Hyperapobetalipoproteinemia

John A. A. Ladias, MD; Peter O. Kwiterovich, Jr, MD; Hazel H. Smith; Michael Miller, MD; Paul S. Bachorik, PhD; Trudy Forte, PhD; Aldons J. Lusis, PhD; Stylianos E. Antonarakis, MD

JAMA. 1989;262(14):1980-1988.


Abstract

A 43-year-old woman with severe coronary artery disease and hyperapobetalipoproteinemia was heterozygous for an abnormal Msp I apolipoprotein B (APOB) gene fragment because of the absence of the Msp I site around codon 4046 in exon 29 of the APOB gene. Using the polymerase chain reaction technique, 134 base pairs containing the mutant Msp I site were amplified, cloned, and sequenced. The mutation was a C to T transition, substituting tryptophan for arginine at amino acid position 4019 of the mature ApoB-100 protein. Seven relatives of the proband had the same mutation, which has been called "ApoB-100 Hopkins." Only three of seven relatives with the mutation had hyperapobetalipoproteinemia; one was borderline while two other relatives without the mutation had hyperapobetalipoproteinemia. Mutant low-density lipoprotein (LDL) was bound and degraded to a greater extent than normal LDL in cultured human fibroblasts. In conclusion, a new mutation, ApoB-100 Hopkins, was not linked to the hyperapobetalipoproteinemia phenotype, which also was segregating in this family. The increased affinity of this mutant LDL for the LDL receptor may be due to a specific effect of ApoB-100 Hopkins or to altered LDL size and composition.

(JAMA. 1989;262:1980-1988)



Author Affiliations

From the Divisions of Genetics (Drs Ladias and Antonarakis) and Lipid Research Atherosclerosis (Drs Kwiterovich, Miller, and Bachorik and Ms Smith), the Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Md; the Department of Medicine, Microbiology and Molecular Biology Institute, University of California at Los Angeles (Dr Forte); and the Donner Laboratory, Berkeley, Calif (Dr Lusis).


Footnotes

Reprint requests to Department of Pediatrics, The Johns Hopkins Hospital, 600 N Wolfe St, CMSC 1004, Baltimore, MD 21205 (Dr Antonarakis).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Denaturing gradient-gel electrophoresis screening of familial defective apolipoprotein B-100 in a mixed Asian cohort: two cases of arginine3500 -> tryptophan mutation associated with a unique haplotype
Choong et al.
Clin. Chem. 1997;43:916-923.
ABSTRACT | FULL TEXT  

Independent Mutations at Codon 3500 of the Apolipoprotein B Gene Are Associated With Hyperlipidemia
Gaffney et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1025-1029.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.